Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial

Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial

Abstract The post-COVID-19 condition (PCC) is a highly debilitating and persistent postinfectious syndrome that affects millions of people worldwide and has no effective treatment. Therapeutic plasma exchange (TPE) has the potential to improve the PCC by clearing the peripheral soluble pro-inflammat...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergio España-Cueto, Cora Loste, Gemma Lladós, Cristina López, José Ramón Santos, Gemma Dulsat, Anna García, João Carmezim, Julia Carabia, Águeda Ancochea, Carla Fernández-Prendres, Cristian Morales-Indiano, Bibiana Quirant, Eva Martínez-Cáceres, Anna Sanchez, Ivonne Graciela Parraga, Anna Chamorro, Alba San José, Elena Abad, Jose A. Muñoz-Moreno, Anna Prats, Carmina R. Fumaz, Roser Coll-Fernández, Carla Estany, Pamela Torrano, Jordi Puig, Bonaventura Clotet, Cristian Tebé, Marta Massanella, Roger Paredes, Lourdes Mateu
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-57198-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41467-025-57198-7

Similar Items